Unicycive Therapeutics, Inc.
UNCY$64M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaLOS ALTOS22 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
UNCY News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxylanthanum Carbonate | Phase 2 | Chronic Kidney Disease Requiring Chronic Dialysis | - | Patent 2030 |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply